Novo Nordisk A/S
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 63.3K
- Market Cap
- $602.2B
- Website
- http://www.novonordisk.com
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
- Conditions
- Interventions
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1000
- Registration Number
- NCT06221969
- Locations
- 🇺🇸
Univ of Alabama_Birmingham, Birmingham, Alabama, United States
🇺🇸Prime Medical Group, LLC, Gilbert, Arizona, United States
🇺🇸Velocity Clinical Research-Phoenix, Phoenix, Arizona, United States
A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 180
- Registration Number
- NCT06207877
- Locations
- 🇩🇪
Parexel International GmbH, Berlin, Germany
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
- Conditions
- Interventions
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 680
- Registration Number
- NCT06200207
- Locations
- 🇵🇹
Hospital da Luz, Lisboa, Portugal
🇵🇹Centro Hospitalar Lisboa Norte, Lisboa, Portugal
🇺🇸Advanced Cardiovascular, LLC, Alexander City, Alabama, United States
A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.
- Conditions
- Interventions
- First Posted Date
- 2024-01-03
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 30
- Registration Number
- NCT06188026
- Locations
- 🇦🇹
Novo Nordisk Investigational Site, Graz, Austria
A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level
- Conditions
- Interventions
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 175
- Registration Number
- NCT06153537
- Locations
- 🇸🇦
My clinic, Jeddah, Saudi Arabia
🇸🇦Al Hammadi, Riyadh, Saudi Arabia
🇸🇦Almoosa Specialist Hospital, Ihsaa, Saudi Arabia
A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults.
- Conditions
- Interventions
- First Posted Date
- 2023-11-15
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 51
- Registration Number
- NCT06133270
- Locations
- 🇬🇧
Northwick Park Hosptial, Watford, Middlesex, United Kingdom
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
- Conditions
- Interventions
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 800
- Registration Number
- NCT06131437
- Locations
- 🇺🇸
Univ of Alabama Birmingham, Birmingham, Alabama, United States
🇺🇸Chambliss Clinical Trials LLC, Montgomery, Alabama, United States
🇺🇸FDRC, Costa Mesa, California, United States
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
- Conditions
- Interventions
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 618
- Registration Number
- NCT06131372
- Locations
- 🇺🇸
Valley Research, Fresno, California, United States
🇺🇸Desert Oasis Hlthcr Med Group, Palm Springs, California, United States
🇺🇸John Muir Physicians Network, Concord, California, United States
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
- Conditions
- Interventions
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 21504
- Registration Number
- NCT06122961
- Locations
- 🇫🇷
Centre Hospitalier Universitaire D'Orleans, ORLEANS Cedex 2, France
🇩🇪Universitätsklinikum Frankfurt aM - Kardiologie, Frankfurt am Main, Germany
🇺🇸Mission Cardiovascular Research Institute, Fremont, California, United States
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
- Conditions
- Interventions
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 10000
- Registration Number
- NCT06118281
- Locations
- 🇺🇸
VA Greater Los Angeles Hlthcare System, Los Angeles, California, United States
🇺🇸University of California, Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸Bridgeport Hospital, Bridgeport, Connecticut, United States